CLINICAL INVESTIGATIONS FOR MEDICAL DEVICES (MDR)
Designing and conducting clinical studies to demonstrate safety, performance, and clinical benefit
Certification of a medical device, according to Regulation (EU) 2017/745, is supported by appropriate clinical data that can confirm or demonstrate its safety, performance or efficacy. Each device has its own pathway: there is no "one-size-fits-all prescription." By designing a pre-market clinical investigation or by designing a proactive post-market surveillance plan, you can collect clinical data, actual use data, feedback, reports, and manage complaints/noncompliance in a structured way.
The study design must be methodologically sound, statistically justified, and consistent with:
- Annex XV MDR
- ISO 14155
- Clinical Evaluation Plan (CEP)
- Risk Management
- Claim and intended use of the device
FTR Advisor supports in defining clinical strategy, methodological design, conducting and reporting of pre-market and PMCF prospective clinical trials.
When is a clinical study required?
A clinical investigation may be required in the following cases:
- Class III and implantable devices
- Inability to demonstrate clinical equivalence
- Innovative devices or devices with new technologies
- New indications for use
- Need to collect new or more data
- Confirm benefit/risk profile
- Verify real-world performance
- Collect data on specific subpopulations
Our methodological approach
1. Defining the clinical strategy
- Analysis of clinical rationale, intended use, and claims
- Check for consistency with defined endpoints with clinical benefits
- Rational justification of sample size
2. Documentary design
Drafting and structuring of:
- Clinical Investigation Design Gantt.
- Synopsis
- Clinical Investigation Plan (CIP)
- Investigator's Brochure
- e-Case Report Form (e-CRF)
- Monitoring Plan
- Documentation for Ethics Committee
- Documentation for Competent Authority
Each document is developed consistent with CEP, GSPR and Risk Management.
3. Study initiation and conduct.
- Coordination with clinical centers
- Monitoring and supervision
- Management of deviations and adverse events
- Quality control of collected data
The goal is to ensure data integrity and regulatory compliance.
4. Statistical analysis and reporting
- Statistical analysis according to predefined plan
- Clinical Investigation Report (CIR)
- Integration of results into the ERC
Why FTR ADVISOR?
- Experience
- Integrated approach: regulatory, clinical, and quality across the lifecycle
- Constant alignment to regulation, guidelines, ISO standards, and practice
- Focus on regulatory risk reduction and rework